Drug Research
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry
As the pharmaceutical market demands in China continue to grow, Chinaโs pharmaceutical policies become gradually clear, which provides broad space for the development of...
News
Continuing the Resplendence with 20 Years Glory, CPhI China Welcomes the Golden Year of Chinese Pharma
As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020 will take place at Shanghai New International...
Techno Trends
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest State of eConsent survey
Signant Health, released the findings from its latest โState of eConsentโ report today, highlighting the sentiments, successes, and challenges of eConsent practitioners around the...
Clinical Trials
VBI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac Meets Primary and Secondary Endpoints
VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported top-line data from CONSTANT, the second pivotal Phase...
Drug Research
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets
IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers...
Drug Research
BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development
BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for...
Drug Research
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf
The new manufacturing facility is designed to have advanced features based on the efficiency of the existing facilities and requires approximately JPY10bn ($90m) in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















